Literature DB >> 7693697

Isolation, partial characterization, and molecular cloning of a human colon adenocarcinoma cell-surface glycoprotein recognized by the C215 mouse monoclonal antibody.

P Björk1, U Jönsson, H Svedberg, K Larsson, P Lind, J Dillner, G Hedlund, M Dohlsten, T Kalland.   

Abstract

The monoclonal antibody C215 (IgG2a) was obtained by the immunization of BALB/c mice with the human colon adenocarcinoma cell line COLO 205 and used in the targeting of colorectal carcinomas. The partial characterization and purification of the C215 target molecule from solubilized COLO 205 membranes indicated that it is an integral membrane glycoprotein of the non-mucin type. The denatured antigen appeared as a major 40-kDa form in Western blots after SDS-polyacrylamide gel electrophoresis and migrated as a monomeric 36-kDa species after the reductive cleavage of intramolecular disulfide bridges. Using a five-step procedure, the antigen was purified 4,300-fold from COLO 205 tumors raised in nude mice to a homogeneity of 95% when assessed by capillary electrophoresis. Removal of N-linked carbohydrate by peptide:N-glycosidase treatment did not affect the visualization of the purified antigen in immunoblots but resulted in a faster migration in the SDS gels. The amino acid sequence was partially determined. Seventeen contiguous NH2-terminal amino acids were identified and coincided exactly with residues 82-98 of the GA733-2 protein cloned by Szala et al. (Szala, S., Froehlich, M., Scollon, M., Kasai, Y., Steplewske, Z., Koprowski, H., and Linnenback, A. J. (1990) Proc. Natl. Acad. Sci. U.S.A. 87, 3542-3546). Therefore, the predicted amino acid sequence of this protein was used to prepare overlapping synthetic peptides that cover the entire extracellular domain in order to identify the C215 epitope. A likely epitope, close to the NH2 terminus and corresponding to the first distinct hydrophilic stretch after the putative signal sequence, was identified in a peptide enzyme-linked immunosorbent assay. Moreover, GA733-2 cDNA was used for the cloning of the C215 protein from COLO 205 cells and the subsequent transfection to K36.16 mouse T cell leukemia cells. The transfected cells were C215 reactive in fluorescence-activated cell sorter analysis, and a 42 kDa band was visualized in Western blots under both non-reducing and reducing conditions. Our findings indicate a close relationship between the C215 antigen and other members of the GA-733 family, some of which are currently being used as targets in clinical trials with monoclonal antibodies. The mammalian expression system described here will enable further studies into the biological role of this protein and the construction of animal models in order to develop optimal therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7693697

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Immunotherapy of human colon cancer by antibody-targeted superantigens.

Authors:  M Dohlsten; P A Lando; P Björk; L Abrahmsén; L Ohlsson; P Lind; T Kalland
Journal:  Cancer Immunol Immunother       Date:  1995-09       Impact factor: 6.968

Review 2.  The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology.

Authors:  Manon J Winter; Iris D Nagtegaal; J Han J M van Krieken; Sergey V Litvinov
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

Review 3.  Monoclonal antibodies and superantigens: a novel therapeutic approach.

Authors:  T Kalland; M Dohlsten; P Lind; A Sundstedt; L Abrahmsén; G Hedlund; P Björk; P A Lando; M Björklund
Journal:  Med Oncol Tumor Pharmacother       Date:  1993

4.  Potential of the trifunctional bispecific antibody surek depends on dendritic cells: rationale for a new approach of tumor immunotherapy.

Authors:  Nina Eissler; Josef Mysliwietz; Nina Deppisch; Peter Ruf; Horst Lindhofer; Ralph Mocikat
Journal:  Mol Med       Date:  2013-04-30       Impact factor: 6.354

Review 5.  Targeting of superantigens.

Authors:  T Kalland; M Dohlsten; L Abrahmsén; G Hedlund; P Björk; P A Lando; A Sundstedt; E Akerblom; P Lind
Journal:  Cell Biophys       Date:  1993 Jan-Jun

6.  Antibody-targeted superantigens are potent inducers of tumor-infiltrating T lymphocytes in vivo.

Authors:  M Dohlsten; J Hansson; L Ohlsson; M Litton; T Kalland
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205

7.  Molecular identification of a human carcinoma-associated glycoprotein antigen recognized by mouse monoclonal antibody FU-MK-1.

Authors:  Y Tomita; F Arakawa; T Yamamoto; M Kuwahara; R Watanabe; H Iwasaki; M Kikuchi; M Kuroki
Journal:  Jpn J Cancer Res       Date:  2000-02

8.  The epithelial cell adhesion molecule EpCAM is required for epithelial morphogenesis and integrity during zebrafish epiboly and skin development.

Authors:  Krasimir Slanchev; Thomas J Carney; Marc P Stemmler; Birgit Koschorz; Adam Amsterdam; Heinz Schwarz; Matthias Hammerschmidt
Journal:  PLoS Genet       Date:  2009-07-17       Impact factor: 5.917

9.  Characterisation of the new EpCAM-specific antibody HO-3: implications for trifunctional antibody immunotherapy of cancer.

Authors:  P Ruf; O Gires; M Jäger; K Fellinger; J Atz; H Lindhofer
Journal:  Br J Cancer       Date:  2007-07-10       Impact factor: 7.640

10.  The tumor targeted superantigen ABR-217620 selectively engages TRBV7-9 and exploits TCR-pMHC affinity mimicry in mediating T cell cytotoxicity.

Authors:  Gunnar Hedlund; Helena Eriksson; Anette Sundstedt; Göran Forsberg; Bent K Jakobsen; Nicholas Pumphrey; Karin Rödström; Karin Lindkvist-Petersson; Per Björk
Journal:  PLoS One       Date:  2013-10-23       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.